Selected article for: "disease progression and fast disease"
Author: Wang, Xia; Sun, Chao; Hu, Hui‐xiu; Wang, Zi‐xin; Wang, Hui; Peng, Hua; Qiao, Jian‐hong; Gao, Lan
Title: Expert consensus on the nursing management of critically ill elderly patients with coronavirus disease 2019
  • Cord-id: 99ns1uzh
  • Document date: 2020_4_12
    • ID: 99ns1uzh
    Snippet: The novel coronavirus (2019‐nCoV) was first detected in patients with pneumonia of an unknown cause in Wuhan, China in December 2019. It has since been confirmed as the pathogen for the new coronavirus pneumonia, recently named “coronavirus disease 2019” (COVID‐19) by the World Health Organization. Although the general population is commonly susceptible to the disease, infected elderly people show fast progression and severe manifestations with a high proportion in critical condition as
    Document: The novel coronavirus (2019‐nCoV) was first detected in patients with pneumonia of an unknown cause in Wuhan, China in December 2019. It has since been confirmed as the pathogen for the new coronavirus pneumonia, recently named “coronavirus disease 2019” (COVID‐19) by the World Health Organization. Although the general population is commonly susceptible to the disease, infected elderly people show fast progression and severe manifestations with a high proportion in critical condition as a result of compromised immunity and underlying diseases. In order to improve the quality of nursing, reduce complications, and decrease mortality of critically ill elderly patients, we assembled a national expert group with expertise in critical nursing to write this consensus, based on a literature review and a subsequent panel discussion. The consensus covers the assessment, clinical nursing, discharge care, and other aspects of care for critically ill elderly patients with COVID‐19, aiming to share insights and provide guidance for clinical practice.

    Search related documents:
    Co phrase search for related documents
    • acid base balance and liver function: 1
    • acid base balance and lopinavir ritonavir: 1, 2, 3
    • acid base balance water electrolyte and lopinavir ritonavir: 1, 2, 3
    • active prevention and acute ards respiratory distress syndrome: 1
    • active prevention and lopinavir ritonavir: 1
    • active treatment and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • active treatment and liver function: 1, 2, 3
    • active treatment and liver injury: 1, 2, 3
    • active treatment and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8
    • acute ards respiratory distress syndrome and liver function: 1, 2, 3, 4, 5, 6, 7, 8
    • acute ards respiratory distress syndrome and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • liver function and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • liver injury and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25